Ivan Horak
Founder & CEO Tikva Allocell
Seminars
Thursday 13th November 2025
Updates in Developing Effective Biomarker Strategies for CAR-T Therapies
9:00 am
- Showcasing progress in CAR-T for hematologic malignancies
- Reviewing updates and innovation in CAR-T for solid tumors
- Exploring updates on prognostic and predictive biomarkers
